Profile and Organization

Names | Figures | Facts

Bayer is a global enterprise with core competencies in the fields of health care, nutrition and high-tech materials. Our products and services are designed to benefit people and improve their quality of life. At the same time we want to create value through innovation, growth and high earning power.

The Group is committed to the principles of sustainable development and to its role as a socially and ethically responsible corporate citizen. Economy, ecology and social responsibility are corporate policy objectives of equal rank. In fiscal 2012, Bayer employed 111,500 people and had sales of €39.8 billion. Capital expenditures amounted to €2 billion, R&D expenses to €3 billion.

Organization

Bayer AG defines common values, goals and strategies for the entire Group. The three subgroups and three service companies operate independently, led by the management holding company. The Corporate Center supports the Group Management Board in its task of strategic leadership.

Business operations are the responsibility of the subgroups:

Bayer HealthCare is among the world’s foremost innovators in the field of pharmaceutical and medical products.
Bayer CropScience is with its highly effective products, pioneering innovations and keen customer focus, holds global leadership positions in crop protection and non-agricultural pest control.
Bayer MaterialScience is a renowned supplier of high-performance materials such as polycarbonates and polyurethanes, and innovative system solutions for a wide range of everyday uses.

Central service functions are combined into three service companies:

Bayer Business Services is the Bayer Group’s international competence center for it-based services.
Bayer Technology Services is the global technological backbone for the Bayer Group and a major innovation driver.
Currenta offers services for the chemical industry including utility supply, waste management, infrastructure, safety, security, analytics and vocational training.

Corporate Governance

Dual governance system with the following governance bodies:

Board of Management:	4 members, Chairman: Dr. Marijn E. Dekkers
Supervisory Board:	20 members, Chairman: Dr. Manfred Schneider

Products

The Bayer Group markets some 5,000 products. Best-sellers include:

in the health care field: Yasmin®/YAZ®/Yasminelle®, Betaferon®/Betaseron®, Kogenate®, Adalat®, Avalox®/Avelox®
in the nutrition field: Confidor®/ Gaucho®/Admire®/Merit®, Flint®/Stratego®/Sphere®
in the field of high-tech materials: Makrolon®, Baydur®, Bayflex® Footwear, Desmodur®/Desmophen®

Locations

Bayer is represented around the world by 283* companies. Global headquarters are in Leverkusen, Germany.

* fully consolidated subsidiaries (as of Dec. 31, 2011)

Workforce

On December 31, 2012, the Bayer Group had 111,500 employees worldwide:

52,300 in Europe

15,300 in North America

26,700 in Asia/Pacific

16,200 in Latin America/Africa/Middle East

Bayer Stock

included in nearly all the major share indices
traded on all German stock exchanges
dividend per share: EUR 1.90

Bayer Group Key Data

Bayer-koncernen	2011 € million	2012 € million	Change %
Net sales	36,528	39,760	+8.8
EBIT	4,149	3,960	-4.6
EBIT before special items	5,025	5,671	+12.9
EBITDA	6,918	6,920	0.0
EBITDA before special items	7,613	8,284	+8.8
Income before income taxes	3,363	3,248	-3.4
Net income	2,470	2,446	-1.0
Earnings per share (in €)	2.99	2.96	-1.0
Gross cash flow	5,172	4,599	-11.1
Netto cash flow	5,060	4,532	-10.4
Capital expenditures	1,666	2,012	+20.8
Research and development expenses	2,932	3,013	+2.8
Dividend per Bayer AG share (€)	1.65	1.90	+15.2